Joining EMBL as a technology developer and engineer Integrated structure and metabolomics platform for microbial targets Supported by the ARISE program, deadline: November 30, 2021
The Wilmanns Group at the EMBL Hamburg Unit aims to establish a multidisciplinary metabolomics/structure service platform for determination of turnover mechanisms of specific drugs or prodrugs by different microorganisms, in collaboration with Michael Zimmermann, Structural & Computational Biology Unit, EMBL Heidelberg. The platform will include establishment of a pipeline for high resolution structures of selected protein-drug complexes in microorganisms, and in-vitro analysis of the enzymatic processing of specific drugs by microorganisms.
In case of further interest please contact: Matthias Wilmanns, email: matthias.wilma...@embl-hamburg.de Michael Zimmermann, email: michael.zimmerm...@embl.de For more information on the position, please visit: https://www.embl.org/jobs/position/EF00004 ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
